Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G6HA
|
|||
Former ID |
DNAP001276
|
|||
Drug Name |
Taliglucerase alfa
|
|||
Synonyms |
Elelyso (TN)
Click to Show/Hide
|
|||
Indication | Metabolic disorder [ICD-11: 5C50-5D2Z; ICD-10: E70-E90; ICD-9: 270-279] | Approved | [1], [2] | |
Company |
Pfizer
|
|||
ADReCS Drug ID | BADD_D02110 | |||
SuperDrug ATC ID |
A16AB11
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glucosylceramidase (GBA) | Target Info | Modulator | [2] |
KEGG Pathway | Other glycan degradation | |||
Sphingolipid metabolism | ||||
Metabolic pathways | ||||
Lysosome | ||||
Pathwhiz Pathway | Sphingolipid Metabolism | |||
Reactome | Glycosphingolipid metabolism | |||
WikiPathways | Sphingolipid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7444). | |||
REF 2 | Nat Rev Drug Discov. 2013 Feb;12(2):87-90. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.